Literature DB >> 622569

Human breast cancer: androgen action mediated by estrogen receptor.

D T Zava, W L McGuire.   

Abstract

Growth of the human breast cancer cell line MCF-7 is enhanced by androgens, but only at pharmacological concentrations. Although physiological concentrations of androgens translocate the androgen receptor into the nucleus, no mitogenic effects are observed. By contrast, pharmacological androgens translocate not only the androgen receptor but also the estrogen receptor, and at these high doses significantly increase both DNA and estrogen-dependent protein synthesis. We therefore propose that androgens stimulate MCF-7 cell growth not through the androgen receptor but rather through the estrogen receptor.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 622569     DOI: 10.1126/science.622569

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  9 in total

1.  High levels of oestrogen receptor-alpha in tumorigenesis: inhibition of cell growth and angiogenic factors.

Authors:  S H Ali; A L O'Donnell; D Balu; M B Pohl; M J Seyler; S Mohamed; S Mousa; P Dandona
Journal:  Cell Prolif       Date:  2001-08       Impact factor: 6.831

2.  17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production.

Authors:  Juliette A Aka; Mausumi Mazumdar; Chang-Qing Chen; Donald Poirier; Sheng-Xiang Lin
Journal:  Mol Endocrinol       Date:  2010-02-19

3.  Estrogen mitogenic action. ii. negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications.

Authors:  D A Sirbasku; J E Moreno-Cuevas
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Jul-Aug       Impact factor: 2.416

4.  Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat.

Authors:  S Dauvois; S M Li; C Martel; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

5.  Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.

Authors:  R Poulin; D Baker; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

6.  Fluoxymesterone stimulation of tumor marker secretion in patients with breast carcinoma.

Authors:  W G Dilley; D E Haagensen; G S Leight; S Ammirata; S R Davis; J S Silva; N Zamcheck; J J Lokich; S A Wells
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 7.  Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?

Authors:  T E Hickey; J L L Robinson; J S Carroll; W D Tilley
Journal:  Mol Endocrinol       Date:  2012-06-28

8.  A complex androgen-responsive enhancer resides 2 kilobases upstream of the mouse Slp gene.

Authors:  F Loreni; J Stavenhagen; M Kalff; D M Robins
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

9.  5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol.

Authors:  G Boccuzzi; E Brignardello; M Di Monaco; V Gatto; L Leonardi; A Pizzini; M Gallo
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.